Lesch-Nyhan syndrome (LNS) is a neurodevelopmental disorder caused by mutations in the gene encoding the purine metabolic enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT). A series of motor, cognitive and neurobehavioral anomalies characterize this disease phenotype, which is still poorly understood. The clinical manifestations of this syndrome are believed to be the consequences of deficiencies in neurodevelopmental pathways that lead to disordered brain function. We have used microRNA array and gene ontology analysis to evaluate the gene expression of differentiating HPRT-deficient human neuron-like cell lines. We set out to identify dysregulated genes implicated in purine-based cellular functions. Our approach was based on the premise that HPRT deficiency affects preeminently the expression and the function of purine-based molecular complexes, such as guanine nucleotide exchange factors (GEFs) and small GTPases. We found that several microRNAs from the miR-17 family cluster and genes encoding GEF are dysregulated in HPRT deficiency. Most notably, our data show that the expression of the exchange protein activated by cAMP (EPAC) is blunted in HPRT-deficient human neuron-like cell lines and fibroblast cells from LNS patients, and is altered in the cortex, striatum and midbrain of HPRT knockout mouse. We also show a marked impairment in the activation of small GTPase RAP1 in the HPRT-deficient cells, as well as differences in cytoskeleton dynamics that lead to increased motility for HPRT-deficient neuron-like cell lines relative to control. We propose that the alterations in EPAC/RAP1 signaling and cell migration in HPRT deficiency are crucial for neuro-developmental events that may contribute to the neurological dysfunctions in LNS.
INTRODUCTION
Lesch-Nyhan syndrome (LNS) is a neurogenetic chronic and progressive disorder caused by mutations in the gene encoding the purine biosynthetic enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT). LNS patients display an array of neurological abnormalities that include mental retardation, delayed development, extrapyramidal motor disturbances and self-injuring behavior (1) . Post-mortem analyses of LNS patient brains have shown alterations of the dopaminergic system in the basal ganglia and midbrain: LNS patients display up to 90% of striatal dopamine loss (2, 3) . The most intriguing aspect of these striatal dopaminergic defects is that they occur, unlike in Parkinson or Huntington diseases, without loss or degeneration of midbrain or striatal neurons or gross neuromorphological abnormalities (2) . Until now, the most cautious and rationale explanation for the neurological aberrations in LNS had been that HPRT deficiency affect developing neurons, particularly during embryogenesis, which leads to disordered brain function. Evidence for this neurodevelopmental * To whom correspondence should be addressed at: 9500 Gilman Drive, La Jolla, CA 92093-0634, USA. Tel: +1 8585341612; Fax: +1 8585341422; Email: gguibinga@ucsd.edu # The Author 2013. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com Human Molecular Genetics, 2013, Vol. 22, No. 22 4502-4515 doi:10.1093/hmg/ddt298 Advance Access published on June 25, 2013 model is supported by recent studies that have demonstrated the dysregulated expression of transcription factors and microRNAs essential to neurodevelopment and neurogenesis (4 -7) . In addition, other studies have also reported defective embryogenic and purinergic signaling in HPRT-deficient cells (8, 9) . However, the mechanisms by which the purine disruption caused by HPRT deficiency can affect the transcriptional and signaling pathways essential to neurodevelopment is unclear.
In the current study, we have hypothesized that the alterations in purine nucleotides pools that occur in HPRT-deficient cells (10) should impact purine-dependent functions, specifically those involving the expression of guanine nucleotide exchange factors (GEFs) and GTPase-based molecular complexes. Our hypothesis was strengthened by a previous report of altered membrane GTPase activity in HPRT-deficient cells (11) . GTP-related functions have a vital role in the developing nervous system since they mediate activities such as cell migration, neurite outgrowth and dendrite architecture, and their dysregulation underlies the phenotype of many neurodevelopmental and neuropsychiatric disorders (12) (13) (14) (15) (16) (17) . In the present study, we have used microRNA array, microRNA-target prediction data and cues from gene ontology (GO) analysis as tools to uncover pattern of expression of several genes encoding GEFs that are dysregulated in HPRT deficiency. Most notably, the genes rapgef3 and rapgef4 encoding the exchange protein directly activated by cyclic AMP 1 and 2 (EPAC1 and EPAC2), respectively; EPAC1 and EPAC2 are GEF for the small GTPase Rap (18) . While EPAC1 is ubiquitously expressed, EPAC2 is abundantly expressed in the brain (19, 20) . EPAC-related signaling mediates a multitude of cellular functions induced by cAMP, including differentiation, proliferation, cell adhesion and migration (18) (19) (20) . Here, we demonstrate that EPAC expression altered in the cortex, the midbrain and the striatum of the HPRTKO mouse; furthermore, EPAC/ RAP1 signaling is blunted in HPRT-deficient cells, which impacts cytoskeletal dynamics and cellular migration and may underlie some of the neurodevelopmental basis of LNS.
RESULTS

MicroRNA expression and functional annotation clustering
We used miRNA array analysis to characterize the miRNA expression signature in differentiating control and HPRT-deficient human dopaminergic neuron-like (SH-SY5Y) cell lines. The data from these arrays identified 21 miRNAs that were differentially expressed between control and HPRT-deficient cell lines (Table 1) . Using TargetScan and TargetMiner (http://www.m irbase.org), we uncovered the genes potentially regulated by each of these 21 miRNAs. The list of each of these predicted target genes was then submitted to DAVID for functional annotation clustering analysis (see Materials and Methods). Initially, we searched for genes encoding for, or associated with macromolecules relevant with purine-nucleotide functions. We therefore extracted the clusters related to broad purine nucleotidebased functions as defined by GO term 'purine-nucleotide binding'. Table 2 summarizes these analyses and shows that a group of dysregulated miRNAs comprising (miR-17, miR-20a, miR-106a, miR-106b and miR-93) has the highest enrichment score (6.45) and they also have the lowest P-value comparatively to other groups of miRNAs (Table 2) for the clusters associated with 'broad purine-nucleotides based function'. The enrichment score is a measure of the incidence to which genes of particular function are present in a cluster. These data show the number of predicted target genes and clusters for each dysregulated miRNAs, the enrichment score and the corrected 'P-value' for the clusters relevant to 'purine-nucleotide binding' biological functions.
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Validation of miRNA expression in human HPRT-deficient neuron-like cell lines and in the cortex, the midbrain and striatal tissues from HPRT knockout mouse
After the identification of miRNAs that potentially regulate genes relevant to broad purine-related biological functions, using QPCR, we set out to confirm the pattern of expression in human HPRT-deficient neuron-like cell lines as well as in the cortex, midbrain and striatum of the HPRTKO mouse. Figure 1A shows significant down-regulation of miR-17, while miR-93 are significantly up-regulated in HPRT-deficient cells compared with control. In the cortex, the expression of miR-106a and miR-93 was significantly diminished in the HPRTKO mouse compared with wild-type (WT) (Fig. 1B) . In contrast, the expression of all the five members of this cluster was significantly up-regulated in the midbrain, while they were significantly down-regulated in the striatum of HPRTKO mice compared with the controls (Fig. 1C and D) .
Expression of miR-17 family cluster in LNS patients
Using fibroblasts isolated several controls (normal, unaffected subjects) and several LNS patients, we examined the expression of each of the five microRNAs that constitute the miR-17 family cluster. Data show that while miR-17 expression is significantly increased, miR-20a and miR-106a expression is significantly reduced in fibroblasts derived from LNS patients comparatively to control subjects. Meanwhile, the level of expression of miR-106b and miR93 was not significantly different for the two groups (Fig. 2) .
Functional annotation analysis generated by DAVID for miR-17, miR-106a, miR-106b miR-20a and miR-93 showing GO terms relevant to guanine-based biology
Having demonstrated altered expression of members of this cluster of miRNA across three important brain regions of the HPRTKO mouse, in human fibroblast cells derived from LNS patients, and in HPRT-deficient neuron-like cell lines, we set out to analyze the predicted target genes of this cluster to uncover pathways that may contribute to the phenotype in HPRT deficiency. We used TargetScan to extract the list of potential target genes for miR-17, miR-20a, miR-106a, miR-106b and miR-93. The combined list submitted to DAVID for functional annotation analysis contained a total of 916 genes. We generated the functional annotation chart for this list and extracted the 15 most relevant terms as defined in their P-value level. Table 3 and Figure 3 show the genes count, the P-value and the pie chart distribution of these terms. Underlined is the one relevant to guanine functions 'guaninenucleotide releasing factor'. By performing additional functional annotation clustering through DAVID, Table 4 shows the cluster containing 27 genes relevant to guanine functions 'guaninenucleotide releasing factor' whose majority are genes encoding various GEF protein or GAP (GTPase activating protein) (see Supplementary Material, Table S2 ). Blunted expression of guanine exchange factor proteins (GEF) in HPRT-deficient neuron-like cell lines
We used QPCR analysis to compare the level of epac1 (rapgef3), epac2 (rapgef4), tiam1, prex1 and vav2 (derived from the list of these 27 genes), in control and HPRT-deficient neuron-like cell lines and in the cortex, the midbrain and the striatum of WT and HPRTKO mice: these GEFs have previously been shown to be involved in neuronal functions (21) (22) (23) . Our data show a significant reduction in mRNA level for epac1, epac2, tiam1, prex1 and vav2 in HPRT-deficient neuron-like cell lines relative to control (Fig. 4A) . Meanwhile, the mRNA expression level for epac1, epac2 and vav2 is also significantly reduced in the striatum of HPRTKO mice relative to their WT counterparts (Fig. 4D) . Conversely, our data also show a statistically significant increase in prex1 and vav2 gene expression in the midbrain and cortex, respectively, for HPRTKO mice relative to WT (Fig. 4B and C) .
Altered expression of EPAC protein and related signaling in HPRT deficiency
We focused on further investigating the signaling and function of epac1 and epac2, two important targets of cAMP, since we have recently demonstrated that HPRT deficiency is associated with altered cAMP signaling in human and mouse neuronal cell lines (24) . We found a significant reduction in EPAC1 and EPAC2 protein in HPRT-deficient human neuron-like cell lines and in the striatum of HPRTKO mice compared with control ( Fig. 5A and D). In contrast, EPAC1 and EPAC2 protein level is increased in the cortex and midbrain of HPRTKO mice relative to control ( Fig. 5B and C). We also demonstrated that the reduction of EPAC1 and EPAC2 expression in HPRT-deficient neuron-like cell lines correlated with a reduction of RAP1 activation in response to the EPAC-specific
Blunted EPAC expression and EPAC-dependent signaling (RAP1) in LNS fibroblasts
To determine whether the alterations in EPAC expression and signaling extend to cells directly derived from LNS patients, we analyzed EPAC expression in fibroblasts cells derived from control and LNS subjects. Our data show, akin to human HPRT-deficient neuron-like cell lines, both Epac1 and Epac2 mRNA ( Fig. 6A ) and EPAC1 protein expression are decreased in LNS fibroblasts (Fig. 6B ). Moreover, EPAC1 protein expression was restored in LNS HPRT-reconstituted fibroblasts (Fig. 6B ). In spite of the detectable level of Epac2 mRNA in these fibroblast cells, we could not detect EPAC2 protein expression (data not shown). Consistent with the reduced level of EPAC1 in LNS-derived fibroblasts, RAP1 activity was also significantly blunted in these cells compared with control: RAP1 signaling could be partly restored in HPRT-reconstituted fibroblasts (Fig. 6C ).
Actin cytoskeleton dynamics and cell migration in HPRT-deficient neuron-like cell lines
There were notable differences in cell morphology of control and HPRT-deficient neuronal-like cell lines. While control cells displayed a cohesive cellular architecture with strong adhesion to collagen matrix, the HPRT-deficient cells show a less cohesive cellular network in culture and were also more prone to detachment than control (data not shown). Additionally, the HPRT-deficient cells had the propensity to assemble in spherical clusters reminiscent of neurospheres (see Supplementary Material, Fig. S1 ). Since EPAC-RAP1 signaling is a known regulator of cell morphology and cell -cell adhesion (19, 20) , we hypothesized that these differences between control and HPRT-deficient neuron-like cells could point to changes in cytoskeleton organization. We set out to investigate F-actin cytoskeleton dynamic using AlexaFluor488 Phalloidin. (Fig. 7B) . Since EPAC-RAP1-related signaling is involved in the regulation of cytoskeleton dynamics, which can control cell migration (25); we used the 'scratch wound' assay to evaluate how EPAC/RAP1 deficit affects the migration of HPRT-deficient neuron-like cells. Figure 7C shows that the Epac-selective analog increases migration of HPRT-deficient cells. Meanwhile, the basal migration of control and HPRT-deficient cells was not significantly different (Fig. 7C ).
Restoring RAP1 in HPRT-deficient cells improves cytoskeletal dynamics and inhibits the motility of HPRT-deficient neuron-like cells
In order to determine the contribution of RAP1 to the disruption of the cytoskeletal dynamic and the motility pattern of HPRT-deficient cells, we set out to restore RAP1 signaling through EPAC expression using an adenoviral vector encoding the EPAC1 gene (Adv-EPAC1). Data show robust expression of EPAC 1 in AdV-EPAC1 infected HPRT-deficient neuron-like cells, which restored RAP1 activation ( Fig. 8A and B) . Furthermore, the restoration of RAP1 signaling also partly enhances the number of halo-shape F-actin fluorescent staining and inhibits the migration of HPRT-deficient cells in response to 8-Pcpt-cAMP similar to that of control cells ( Fig. 8C and D) .
DISCUSSION
In the present study, we report differential expression of miRNAs in control and HPRT-deficient neuron-like cell lines. In the context of HPRT deficiency and LNS, whose etiology is complex and still not well understood, microRNA technology provides a novel way to uncover dysregulated gene expression across distinct pathways. We uncovered that nearly two dozen of microRNAs are aberrantly expressed between differentiated control and HPRT-deficient neuron-like cells (Table 1) ; these microRNAs could potentially regulate thousand of genes and therefore affect the signaling of hundreds of pathways within HPRT-deficient cells. In the face of potential broad and complex alterations, we set out to use the microRNA-array data and the GO analysis provided by DAVID as a guiding tool that could allow us to uncover dysregulated genes and pathways in HPRT deficiency. Since it is known that alterations of purine metabolism are associated with HPRT deficiency, we used DAVID to identify miRNAs that could regulate genes implicated in broad-purinebased functions. We identified that the miR-17 family cluster had a high enrichment score relevant to broad-purine-based functions (Table 2) . We confirmed the significant dysregulated expression of several members of this group of miRNAs in HPRT-deficient neuron-like cell lines, in regions of the brain of the HPRTKO mouse (cortex, midbrain and striatum) and in fibroblast cells from LNS patients, providing evidence that members of miR-17 cluster have a role in the etiology of HPRT deficiency. Our data showing differential pattern of miRNAs expression for various regions of the brain and for the different cells suggest that the molecular adaptations to HPRT deficiency are brain region and cell specific. We also investigated the potential targets for miR-17 family cluster and uncovered several genes that were significantly dysregulated in HPRT-deficient cells, the cortex, the striatum and the midbrain of HPRTKO mice specifically, tiam1, pREX1, Vav2, epac1 and epac2. These guanine exchange factor proteins have an important role in neuronal functions. For instance, in mice, tiam1, a Rac-GEF is highly expressed in the regions of developing brain and plays a critical role in brain development (26) , and prex1 and vav2 genes are involved in neuronal migration and neurite differentiation and outgrowth (22, 23) . We found aberrant and often opposite pattern of expression for epac1, epac2, vav2, tiam1 and prex1 genes in HPRT-deficient neuron-like cell lines and in the cortex, the striatum and the midbrain of HPRTKO mice, which again suggests that molecular and cellular alterations triggered by HPRT deficiency could be specific to brain regions and hence may contribute to the complexity of the LNS neurological phenotype. While members of miR-17 cluster and GEF genes are highly expressed in the regions of mouse brain examined, the current study does not show evidence of correlation between the level of expression for miRNAs and GEF genes such as EPAC1 and EPAC2. We further investigated the role of EPAC in HPRT deficiency since we have highlighted abnormal cAMP-related signaling in HPRT-deficient cells and it is a cAMP downstream mediator (24) . EPAC-related abnormalities have been implicated in others neurodevelopmental disorders (15, 27, 28) . EPAC mediates a multitude of cAMP-dependent functions, such cell proliferation, adhesion, migration, differentiation and apoptosis (20) . Our data suggest that EPAC may also have a role in HPRT deficiency and this may provide a novel mechanistic insight into the molecular and cellular basis of LNS.
For the current study, we used HPRT knockdown neuron-like cell lines and brain tissues from HPRTKO mice, but due to the lack of availability of brain samples derived directly from LNS patients, we use primary fibroblast cells to infer that dysregulated EPAC expression and signaling might also be altered in LNS. While we recognize that fibroblasts and neurons possess a very distinct transcriptional and signaling profile, fibroblast cells derived from LNS patients have often validated gene expression abnormalities relevant to neuronal functioning (6) . Furthermore, since the rescue of HPRT expression and activity in LNS-derived fibroblast cells restores the EPAC expression and signaling, these data then support the hypothesis that HPRT can regulate EPAC expression and signaling.
Blunted EPAC expression and function could potentially affect two major aspects of LNS etiology, (i) neurodevelopment and (ii) neuronal function. LNS-mediated neurodevelopment deficit could be in part caused by altered cell migration, which depends on changes in cell -cell adhesion and extracellular matrix interactions that are partly regulated by EPAC/RAP1 signaling (18, 19) . Since we found that EPAC/RAP1 signaling is blunted in HPRT-deficient neuron-like cells leading to an increase to their motility in the presence of an EPAC-agonist, our data suggest that the altered response to migratory cues during neurogenesis could be one of the main underpinning of LNS-mediated neurodevelopmental phenotype. The rescue of RAP1 signaling through the expression of EPAC1 in HPRT-deficient cells could partly restore the cytoskeletal and migration ( Fig. 8C and D) ; thus supporting the notion that these cellular abnormalities are partly mediated by the absence of RAP1. HPRT deficiency is likely to reverberate beyond the neurodevelopmental process and extend to neuronal function. EPAC and other GEF proteins are known regulator of neurite outgrowth (18, 29, 30) . We and others have previously demonstrated neurite outgrowth insufficiencies in murine and human HPRT-deficient neurons-like cell lines compared with control (4,31). The decrease in GEF proteins, including EPAC in HPRT deficiency, may provide an appropriate explanation for this earlier reported neurite outgrowth deficits in HPRTdeficient cells. Neuronal branching aberrations have long been suggested as plausible mechanism of LNS neuro-related dysfunction (32, 33) ; a characteristic that has since been confirmed in vivo using the HPRTKO mouse model (34) . The detail analyses of cortical and striatal neurons from these animals show reduced dendrites extension and abnormal dendritic spines morphology (34) . Also, recent studies have clearly established the role of EPAC in the regulation of basal dendrite, as well as dendritic spines in mice, where in vivo EPAC2 knockdown in cortical neurons interfere with the dendrites architecture (15). The potential targets genes were extracted from the targetScan database. The table shows DAVID analysis for the cluster with GO terms relevant to guanine-related functions, 'guanine-nucleotide releasing factor' which contains 27 genes that are in boldface (see Supplementary Material, Table S2 ).
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The in vivo neuronal morphological highlighted by these EPAC studies (15) are akin to those previously identified in striatal and cortical neurons of the HPRTKO mouse model (34) . Our data showing dysregulated expression of EPAC in the cortex, the midbrain and the striatum of HPRTKO mice provides a new context for these previously documented neuro-morphological aberrations. In addition, since EPAC plays an important role in regulating neurotransmitter release and synaptic plasticity (35) (36) (37) (38) (39) , the marked reduction in EPAC expression in the striatum of the HPRTKO mice may contribute to the reduced level of dopamine neurotransmitter in the striatum or the basal ganglia of HPRTKO mice or LNS patients. Collectively, this study suggests a rationale mechanistic base for the purinemetabolism deficiency in LNS affecting small GTPase such as RAP1; the aberrant RAP1 signaling could affect coordinately or in cascade neuronal cells migration, neurite outgrowth, spine morphology and neurotransmitter release to contribute to the complex and still poorly understood LNS neurological phenotype (Fig. 9 ).
MATERIALS AND METHODS
Cells
Human SH-SY5Y neuron-like cell lines were obtained from ATCC and maintained in a 1:1 mixture of Eagle's minimum essential medium and F12 Medium (Life Technologies) containing 10% fetal bovine serum (FBS) and 50 mg/ml penicillin/ streptomycin (Life Technologies) in 5% CO 2 atmosphere. The primary human fibroblasts, kindly provided by Dr Jinnah (Emory University), were cultured in DMEM medium supplemented with 10% FBS, 50 mg/ml penicillin/streptomycin.
Animals
The HPRT knockout mouse model has been previously described (40) . Brain tissues encompassing the prefrontal cortex, the striatum and the midbrain of at least three adult male WT or three adult male HPRTKO mice were collected and sonicated in homogenizing buffer (1% SDS, 50 mM NaF). The protein concentration of the homogenate was determined by BCA protein assay and processed for immuno-blot as described below. Alternatively, the brain tissues from the same regions (cortex, striatum and midbrain) were rapidly frozen under powdered dry ice for RNA extraction using RNA extraction procedures indicated below. Mouse housing and euthanasia for tissues collection were performed in compliance with federal and UCSD institutional guidelines.
HPRT and luciferase small hairpin oligonucleotides and knockdown vectors
The short hairpin RNA sequences against the luciferase and HPRT genes were selected and prepared as previously described (4).
HPRT knockdown and selection of HPRT-deficient human neuron-like cell lines
Cells were infected at a multiplicity of infection (MOI) of approximately 1 with the knockdown vectors retrosh2hprt or control vector retroshlux. Infected cells were grown for 10 days in complete DMEM medium containing 3 mg/ml of puromycin. Bulk cultures were re-plated and maintained in DMEM without puromycin selection for additional 7 days, after which, cells were examined for HPRT expression by QPCR, western blot and by transfer to the culture medium containing 250 mM 6-thioguanine (6-TG) (SIGMA). The cells infected with the HPRT knockdown vector retrosh2hprt showed unimpeded growth and expansion in 6-TG, while the control cells infected with retroshlux were unable to grow in 6-TG (data not shown). The level of HPRT gene knock-down in these cells has previously been described and is estimated to be 95-98% as evaluated by QPCR, meanwhile the level of HPRT enzymatic activity showed a reduction of 75% (8) .
Differentiation of human SH-SY5Y cell lines
HPRT-deficient and control SH-SY5Y cell lines were differentiated using an established retinoic acid-based differentiation protocol (41, 42) . The cells were trypsinized and plated on collagen-coated plates (BD Biosciences) at 2 × 10 5 cells/ml density in a 10 cm plate. The growth medium was supplemented with retinoic acid at a final concentration of 10 mM. After 5 days, the cells were washed with PBS and incubated with 50 ng/ml of brain-derived neurotrophic factor (R&D Systems) in the growth medium without serum for 7 days. MiRNA and mRNA were extracted from each population of neuron-like-like cells.
Total RNA isolation and quantitative PCR analysis
Total RNA was isolated using PureLink TM RNA Mini kit for control and HPRT-deficient cells, according to the manufacturer's instructions (Life Technologies). RNA quantity, quality and integrity were evaluated using the RNA 6000 Labchip kit on the Agilent 2100 Bioanalyzer (Agilent Technologies). Five hundred nanograms of the resulting RNA was used for a reverse transcription reaction using Qiagen miScript Reverse Transcription Kit according to the manufacturer's instructions (Qiagen). The synthesized cDNA was used for QPCR analysis using a Qiagen miScript kit which permits quantification of mature miRNA and mRNA from the same cDNA sample. All PCR primers used in the following studies are listed in Supplementary Material, Table S1 . The quantitative PCR was carried, using the Opticon 2 system DNA engine (BioRad, Hercules, CA, USA) and primers specific for the glyceraldehyde-3-phosphate dehydrogenase (GAPDH), U6 and 18 s were used as normalization controls. Differences of expression between control and knockdown groups were calculated by normalizing Ct values of the test genes to the Ct values of an endogenous control (GAPDH, U6 18 s for mRNA or miRNA). The fold change or difference in mRNA expression was calculated using the equation 2-DDCt (43). The statistical significance for variation of expression was assessed by comparing DCt of each group by Student's t-test.
MicroRNA arrays and data analysis
Ncode TM human miRNA Microarray V3 (Life Technologies) was used for expression array analysis, under conditions recommended by the manufacturer (NCode human miRNA Microarray V3, http://invitrogen.com, Catalog #: MIRH3-05). Briefly, this array consists of Epoxide-coated glass slides, onto which are printed probe sequences targeting all known mature miRNAs available in the miRbase sequence Sanger database, Release 10.0 (http://microrna.sanger.ac.uk). The arrays also contain positive controls for hybridization validation using the multi-species miRNA array, as well as Alexa Fluor Dye control probes for easy normalization of signal intensities and mismatch controls for screening 1 and 2 base sequence mismatched dye control. 0.5-5 mg of RNA were labeled using the Ncode rapid miRNA labeling system which makes use of Alexa Fluor Labeling technology (NCode Rapid miRNA Labeling System at http://invitrogen.com, Catalog # MIRLSRPD-20). Firstly, poly (A) tailing of total RNA was carried out in 10× miRNA reaction buffer containing 25 mM MnCl 2 , 0.1 mM ATP in the presence of poly A polymerase and incubated at 378C for 15 min. Subsequently, the ligation of poly-tailed RNA was carried out according to the manufacturer's instructions in a reaction mixture containing 6X Alexa Fluor ligation mix (Cy3 or Cy5), NCode dye normalization control and the ligase enzyme. The ligation cocktail was incubated in light-free conditions at room temperature for 30 min. The ligations were terminated by adding the NCode stop solution at room temperature. Following the ligation, the labeled miRNA as well as the appropriate controls were mixed in 2X enhanced Hyb buffer (Life Technologies), incubated for 658C for 10 min in the dark. The hybridization cocktail was then added to the array slide in the hybridization chamber (Corning), and the hybridization chamber was placed in an incubator at 528C overnight (8 -20 h). Following hybridization, arrays were removed from the chamber, and the slides were washed twice in 2X SSC, 0.2% SDS washing buffer at room temperature and once in 0.2 SSC washing buffer also at room temperature. The slides were subsequently dried by centrifugation for 4 min at 600 g at room temperature and scanned using Genepix 4000B Scanner (Molecular Devices, Downingtown, PA, USA) within 30 min after the final wash to avoid photo-bleaching. MicroRNA expression was analyzed in control and HPRT-deficient groups using NCode profiler software tool (NCode Profiler User Guide, http:// invitrogen.com). Scanned arrays in the GenePix format were imported into the NCode profiler in which only positive data are used by the profiler algorithms. The NCode profiler analysis output file was formatted according to manufacturer's recommendations (NCode Profiler User Guide, http://invitrogen.com). 
Gene annotation analyses clustering and GO analysis
To identify target genes of dysregulated microRNAs and determine their possible relevance to the aberrant guanine-related cellular signaling in the phenotype of HPRT deficiency, we extracted the predicted target genes from the miRNA database Target-Miner and TargetScan (http://www.mirbase.org). We subsequently analyzed the list of genes using DAVID (Data annotation for visualization of integrated discovery). In DAVID, we used the functional annotation chart and classification clustering which is a tool which organizes genes into functionally related clusters. Within each cluster are GO categories of genes having similar biological significance (44-46).
8-pCPT-2 ′ -O-Me-cAMP analog treatment assay
Control and HPRT-deficient cells were seeded in six-well plate to reach 80% confluence, and treated with vehicle PBS (control) and up to 100 mM of 8-pCPT-2 ′ -O-Me-cAMP (from Axxora, Farmingdale, NY, USA) for 15 min in serum free conditions. The reaction was terminated by removal of the medium and the subsequent addition of mammalian protein extraction reagent (M-PER from Thermo-Scientific) and protease inhibitors cocktail (From Sigma). Cell lysate was recovered and processed for protein quantification and immuno-blot analysis as described below.
RAP1 activation assay
RAP1 activity was assessed using the 'Active RAP1 pull-down and detection kit' (Thermo Scientific, Rockford, IL, USA, #16120) according to the manufacturer's instruction. Briefly, cell lysates derived from control and HPRT-deficient cells treated 8-pCPT-2 ′ -O-Me-cAMP or PBS then incubated with Rap-binding domain RalGDS-RBD-GST and loaded on a western-blot and probed with anti-RAP1 antibody.
Immuno-blot
Cells were cultured and treated as indicated above, and subsequently lysed using mammalian protein extraction reagent (M-PER from Thermo-Scientific) and the protease inhibitor mixture, 1 mM PMSF, 1 mM sodium orthovanadate (all from Santa Cruz Inc). The cell lysates were centrifuged 15 000g at 48C for 10 min. Protein concentration assays of supernatant were carried out by BCA assay (Thermo Scientific) and 20-30 mg of the lysates (from cells and tissues) were then separated by reducing Tricine SDS-PAGE and the separated protein bands were transferred onto polyvinylidene fluoride (PVDF) membrane (Life Technologies) using Mini Trans-Blot Electrophoretic Transfer Cell (BioRad). Blotted PVDF membranes were blocked by blocking solution containing 5% bovine serum albumin, 20 mM of Tris, 137 mM of NaCl and 0.1% of Tween-20 (Sigma-Aldrich) for 1 h at room temperature. Immuno-detection of primary antibodies was carried out overnight at 48C and signal amplification using horseradish peroxidase (HRP)-conjugated secondary antibody was performed at Human Molecular Genetics, 2013, Vol. 22, No. 22 4511 room temperature for 1 h. The chemiluminescence reagent SuperSignal West Pico (Thermo Scientific) was used as signal amplification reagent. The X-ray films were developed by SRX101A film processor (Konica Minolta, Motosu-shi, Gifu-ken). All primary and secondary antibodies were diluted in blocking solution. The primary polyclonal rabbit antibody against GAPDH was obtained from Cell Signaling Technology w (cellsignaling.com). EPAC1 and EPAC2 were obtained from AbCAM and Santa Cruz biotechnology, respectively. All antibodies were used at dilutions ranging from 1:500 to 1:1000. The secondary IgG antibodies against the corresponding primary antibodies were labeled with HRP (from Santa Cruz) and used at the dilution 1:20 000. The immuno-blot signal was quantified using densitometry ImageJ software according to the protocol published at http://openwetware.org/wiki/Bitan: densitometry. Expression of beta-actin (Santa Cruz) and GAPDH (cell signaling technology) was used as a loading normalization control.
Migration assay
The migration of control and HPRT-deficient cells was determined by 'scratch wound' assay (47, 48) . Briefly, control and HPRT-deficient neuron-like cell lines were grown onto collagen-coated plates to reach confluence forming a monolayer covering the surface of the entire plate (12-well plate). Cells were serum-starved and treated with either PBS (vehicle) or 8-pCPT-2 ′ -O-Me-cAMP overnight. Afterward, the wound was created at the edge of the cell monolayer by the gentle removal of the attached cells with a sterile plastic pipette tip. The cell debris was removed and the cells were re-exposed to PBS or 8-pCPT-2 ′ -O-Me-cAMP, still in serum free conditions. The migration of the cells after 24 h was evaluated by examining the 0 and 24-h phase-contrast micrographs and measuring the surface area or perimeter of the wound using ImageJ and Meta-Morph imaging and morphometry (Molecular Devices).
Immunocytochemistry
Control and HPRT-deficient cells were seeded on collagencoated cover slips and fixed with 4% paraformaldehyde, and permeabilized with 0.5% Triton-X-100 in 3% horse serum for 15 min and then blocked for 1 h in 3% horse serum in PBS. The fixed cells were incubated with Alexa-Fluor Images were captured at ×20 in a fluorescent field and imported into MetaMorph imaging and morphometric software (Molecular Devices) for counting the fluorescent F-actin cells. Counted cells were of a predefined cellular morphology and consisted of contiguous halo-like shape cells with peripheral fluorescent F-actin staining. Cells were counted from at least four different microscopy fields each for control and HPRT-deficient neuronlike cell lines.
Viral vectors preparation
Lentivirus-based plasmids expressing GFP and HPRT genes were generated by inserting cDNA for GFP (obtained by PCR from p-EGFP-N1 cloning vector, from Clontech), and cDNA from HPRT (from OriGene) into pSin-EF2-Puro (from Addgene) using SpeI and EcoRI restriction site. pSin-EF2-Puro contains a constitutively active promoter from human elongation factor and a puromycin resistance marker for selection of stable transfectants. VSV-G pseudotyped lentivirus-based vectors expressing GFP as well as HPRT were prepared by using HEK 293 T subjected to the established triple transduction protocol (49, 50) . Adenoviral vectors containing GFP and EPAC1 gene were purchased from Vector Biolabs. HPRT-deficient cells were infected with adenoviruses at a MOI of 100. All experiments were carried out 48 -72 h after infection.
HPRT expression rescue
LNS-derived fibroblasts cells were infected at the MOI of 10 using GFP or HPRT encoding lentivirus vectors. Forty-eight hours after infection, the cells were selected in puromycin (1 mg/ml) for an additional 7 days. The HPRT phenotype in the infected cells was confirmed by growing the cells in 250 mM of 6-TG (SIGMA) and in 1X hypoxanthine aminopterin thymidine (HAT) medium (from ATCC). The growth of the Figure 9 . Proposed model of HPRT deficiency altering guanine-based cellular functions and impacting the neurological phenotype in LNS. HPRT deficiency creates changes in purine pools and microRNAs expression profile that coordinately alter the expression of genes encoding guanine nucleotide exchange factor (GEF) such as EPACs. The dysregulation of these GEF affects the signaling cascade of small GTPase like RAP1. Furthermore, these small GTPases control the actin dynamic which in turn affects several neuronal-related functions; (1) during the neurodevelopment these dysregulations will likely impact cell migration, and neurite outgrowth to possibly affect neuronal specificity; (2) in mature neurons, deficit in GTPases and actin dynamic could cause alteration in spine morphology and neurotransmitter release that would perturb synaptic plasticity. We propose that HPRT deficiency creates neuronal specificity alterations during neurodevelopment and neurotransmission abnormalities in mature neurons that collectively contribute to the LNS neurological phenotype.
GFP-infected HPRT-deficient fibroblast cells remains unaltered in 6-TG, while it was severely impaired in HAT. Conversely, HPRT-reconstituted LNS fibroblasts cells were now displaying altered growth in 6-thioguanine and unimpaired expansion in HAT. The HPRT phenotype of LNS fibroblast infected cells was genotypically confirmed using QPCR (data not shown and western-blot against HPRT).
Statistical analysis
Statistical analyses were carried out using Kaleidagraph graphing and data analysis software package (Synergy Software, Reading, PA, USA). The data are reported as mean + standard error. For most analyses, Student paired t-test was performed for control and experimental groups. One-way ANOVA with Tukey post hoc test was also performed. For most analyses, statistical significance was set at P , 0.05.
